276 related articles for article (PubMed ID: 32596075)
41. A rare case of spontaneous tumor lysis syndrome in multiple myeloma.
Aldabain L; Camire L; Weisman DS
J Community Hosp Intern Med Perspect; 2020 Aug; 10(4):365-368. PubMed ID: 32850100
[TBL] [Abstract][Full Text] [Related]
42. Spontaneous tumor lysis syndrome (STLS) during biopsy for burkitt lymphoma: a case report.
Pan S; Shen Q; Zhou J; Li T
BMC Pediatr; 2024 Mar; 24(1):209. PubMed ID: 38521927
[TBL] [Abstract][Full Text] [Related]
43. Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults.
McDonnell AM; Lenz KL; Frei-Lahr DA; Hayslip J; Hall PD
Pharmacotherapy; 2006 Jun; 26(6):806-12. PubMed ID: 16716134
[TBL] [Abstract][Full Text] [Related]
44. Rasburicase for the treatment of tumor lysis in hematological malignancies.
Malaguarnera G; Giordano M; Malaguarnera M
Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702
[TBL] [Abstract][Full Text] [Related]
45. Spontaneous tumor lysis syndrome in a patient with cholangiocarcinoma.
Ali AM; Barbaryan A; Zdunek T; Khan M; Voore P; Mirrakhimov AE
J Gastrointest Oncol; 2014 Apr; 5(2):E46-9. PubMed ID: 24772347
[TBL] [Abstract][Full Text] [Related]
46. FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk.
Spina M; Nagy Z; Ribera JM; Federico M; Aurer I; Jordan K; Borsaru G; Pristupa AS; Bosi A; Grosicki S; Glushko NL; Ristic D; Jakucs J; Montesinos P; Mayer J; Rego EM; Baldini S; Scartoni S; Capriati A; Maggi CA; Simonelli C;
Ann Oncol; 2015 Oct; 26(10):2155-61. PubMed ID: 26216382
[TBL] [Abstract][Full Text] [Related]
47. Evaluation and characterization of tumor lysis syndrome before and after chemotherapy among pediatric oncology patients in Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
Micho H; Mohammed Y; Hailu D; Genet S
BMC Hematol; 2018; 18():22. PubMed ID: 30186610
[TBL] [Abstract][Full Text] [Related]
48. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
[TBL] [Abstract][Full Text] [Related]
49. Management of pediatric tumor lysis syndrome.
Tazi I; Nafl H; Elhoudzi J; Mahmal L; Harif M
Arab J Nephrol Transplant; 2011 Sep; 4(3):147-54. PubMed ID: 22026339
[TBL] [Abstract][Full Text] [Related]
50. Rasburicase for the management of tumor lysis syndrome in neonates.
McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
[TBL] [Abstract][Full Text] [Related]
51. Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.
Mirrakhimov AE; Ali AM; Khan M; Barbaryan A
Rare Tumors; 2014 May; 6(2):5389. PubMed ID: 25002953
[TBL] [Abstract][Full Text] [Related]
52. A case of spontaneous tumor lysis syndrome in extensive-stage small-cell lung cancer: A rare oncologic emergency.
Alan AM; Alan O
Turk J Emerg Med; 2020; 20(3):142-145. PubMed ID: 32832733
[TBL] [Abstract][Full Text] [Related]
53. Tumor lysis syndrome in solid tumors: Clinical characteristics and prognosis.
Caravaca-Fontán F; Martínez-Sáez O; Pampa-Saico S; Olmedo ME; Gomis A; Garrido P
Med Clin (Barc); 2017 Feb; 148(3):121-124. PubMed ID: 27993406
[TBL] [Abstract][Full Text] [Related]
54. How we treat tumor lysis syndrome.
Muslimani A; Chisti MM; Wills S; Nadeau L; Zakalik D; Daw H; Huang J; Jaiyesimi I
Oncology (Williston Park); 2011 Apr; 25(4):369-75. PubMed ID: 21618960
[TBL] [Abstract][Full Text] [Related]
55. Management of tumor lysis syndrome in adults.
Coiffier B; Riouffol C
Expert Rev Anticancer Ther; 2007 Feb; 7(2):233-9. PubMed ID: 17288532
[TBL] [Abstract][Full Text] [Related]
56. Tumor lysis syndrome associated with docetaxel and carboplatin in a case with recurrent endometrial cancer.
Ito T; Ohta T; Narumi M; Sakaki H; Seino M; Sudo T; Nagase S
Gynecol Oncol Rep; 2018 May; 24():21-23. PubMed ID: 29845102
[TBL] [Abstract][Full Text] [Related]
57. Tumor lysis syndrome and metastatic melanoma.
Meeks MW; Hammami MB; Robbins KJ; Cheng KL; Lionberger JM
Med Oncol; 2016 Dec; 33(12):134. PubMed ID: 27807723
[TBL] [Abstract][Full Text] [Related]
58. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.
McBride A; Westervelt P
J Hematol Oncol; 2012 Dec; 5():75. PubMed ID: 23237230
[TBL] [Abstract][Full Text] [Related]
59. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.
Gouveia HS; Lopes SO; Faria AL
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434
[TBL] [Abstract][Full Text] [Related]
60. Recombinant urate oxidase (rasburicase) in the prophylaxis and treatment of tumor lysis syndrome.
Jeha S; Pui CH
Contrib Nephrol; 2005; 147():69-79. PubMed ID: 15604607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
